Clinical Trials Directory

Trials / Conditions / Acquired Hemophilia A

Acquired Hemophilia A

10 registered clinical trials studyying Acquired Hemophilia A — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea
NCT06550882
Takeda—
RecruitingA Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A
NCT06461533
Takeda—
Active Not RecruitingEmicizumab in Patients With Acquired Hemophilia A
NCT05345197
University of WashingtonPhase 2
CompletedStudy of TAK-672 in Participants With Acquired Hemophilia A
NCT04580407
TakedaPhase 2 / Phase 3
UnknownStudy to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A
NCT03700229
Peking Union Medical College HospitalPhase 2
CompletedTrial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituxim
NCT03384277
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 4
CompletedProspective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in
NCT03199794
Baxalta now part of Shire—
CompletedPost-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patien
NCT02610127
Baxalta now part of Shire—
CompletedStudy of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A
NCT01178294
Baxalta now part of ShirePhase 2 / Phase 3
No Longer AvailableExpanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemop
NCT01968655
Baxalta now part of Shire—